Preconditioning with sevoflurane decreases PECAM-1 expression and improves one-year cardiovascular outcome in coronary artery bypass graft surgery. [electronic resource]
Producer: 20050303Description: 159-65 p. digitalISSN:- 0007-0912
- Adult
- Aged
- Aged, 80 and over
- Anesthetics, Inhalation -- therapeutic use
- Cardiotonic Agents -- therapeutic use
- Coronary Artery Bypass
- Disease-Free Survival
- Female
- Heart Diseases -- prevention & control
- Humans
- Ischemic Preconditioning, Myocardial -- methods
- Male
- Methyl Ethers -- therapeutic use
- Middle Aged
- Platelet Endothelial Cell Adhesion Molecule-1 -- blood
- Postoperative Complications -- prevention & control
- Prospective Studies
- Sevoflurane
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.